XDR-TB

tuberculosis, STREAM clinical trial, TB research, infectious diseases, New England Journal of Medicine, UN General Assembly, Pretomanid, TB vaccine, MDR TB, XDR TB,

India Can Be a Global Leader in TB Research

A health technician analyses blood samples for tuberculosis testing in a high-tech tuberculosis lab in Carabayllo in Lima, Peru May 19, 2016. Credit: Reuters

Only Handful in India Will Have Access to TB ‘Wonder Drug’ Delamanid Next Month

Scanning electron micrograph of Mycobacterium tuberculosis bacteria, which cause TB. Caption and credit: NIAID

While India Begins to Get Its Anti-TB Act Together, a New Model Has Predicted Newer Threats

In India’s Fight Against Tuberculosis, Diagnostics Remains Poorly Understood